| 0 |
FOETAL BIOPHYSICAL PROFILE SCORE |
1 |
0.3333 |
| 1 |
ENCEPHALITIS CYTOMEGALOVIRUS |
70 |
0.1598 |
| 2 |
PNEUMOTHORAX SPONTANEOUS TENSION |
1 |
0.1429 |
| 3 |
CYTOMEGALOVIRUS TEST NEGATIVE |
1 |
0.1250 |
| 4 |
URINE CYTOMEGALOVIRUS POSITIVE |
1 |
0.1250 |
| 5 |
VIRUS URINE TEST POSITIVE |
1 |
0.0769 |
| 6 |
PLACENTAL HYPERTROPHY |
3 |
0.0750 |
| 7 |
ANTI-ERYTHROCYTE ANTIBODY |
1 |
0.0714 |
| 8 |
MYOCARDITIS TOXOPLASMAL |
1 |
0.0588 |
| 9 |
HEPATITIS B CORE ANTIGEN POSITIVE |
2 |
0.0526 |
| 10 |
EPSTEIN-BARR VIRAEMIA |
57 |
0.0514 |
| 11 |
CONGENITAL HEPATOMEGALY |
2 |
0.0455 |
| 12 |
VASA PRAEVIA |
1 |
0.0370 |
| 13 |
ANTI A ANTIBODY POSITIVE |
2 |
0.0364 |
| 14 |
DELAYED HAEMOLYTIC TRANSFUSION REACTION |
2 |
0.0339 |
| 15 |
RENAL TRANSPLANT FAILURE |
30 |
0.0304 |
| 16 |
RENAL GRAFT LOSS |
2 |
0.0247 |
| 17 |
BK VIRUS INFECTION |
68 |
0.0201 |
| 18 |
CYTOMEGALOVIRUS SYNDROME |
3 |
0.0182 |
| 19 |
CONGENITAL CYTOMEGALOVIRUS INFECTION |
3 |
0.0176 |
| 20 |
RETINAL SCAR |
8 |
0.0174 |
| 21 |
MENINGOENCEPHALITIS AMOEBIC |
1 |
0.0172 |
| 22 |
CYSTITIS HAEMORRHAGIC |
64 |
0.0159 |
| 23 |
CYTOMEGALOVIRUS GASTRITIS |
4 |
0.0158 |
| 24 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
69 |
0.0156 |
| 25 |
NEPHRECTOMY |
22 |
0.0148 |
| 26 |
VIRAL MYELITIS |
1 |
0.0145 |
| 27 |
CYTOMEGALOVIRUS DUODENITIS |
1 |
0.0143 |
| 28 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
30 |
0.0128 |
| 29 |
GASTROENTERITIS ASTROVIRAL |
1 |
0.0125 |
| 30 |
PNEUMONIA CYTOMEGALOVIRAL |
24 |
0.0123 |
| 31 |
ANTI-ERYTHROCYTE ANTIBODY POSITIVE |
1 |
0.0122 |
| 32 |
ULTRASOUND FOETAL ABNORMAL |
1 |
0.0119 |
| 33 |
CYTOMEGALOVIRUS VIRAEMIA |
51 |
0.0115 |
| 34 |
VIRAL UVEITIS |
1 |
0.0103 |
| 35 |
HUMAN EHRLICHIOSIS |
2 |
0.0096 |
| 36 |
CYTOMEGALOVIRUS CHORIORETINITIS |
18 |
0.0092 |
| 37 |
PELVIC KIDNEY |
1 |
0.0086 |
| 38 |
NEPHROPATHY TOXIC |
90 |
0.0080 |
| 39 |
RENAL REPLACEMENT THERAPY |
1 |
0.0078 |
| 40 |
BACTERIAL TOXAEMIA |
1 |
0.0078 |
| 41 |
PERITONEAL EFFUSION |
1 |
0.0074 |
| 42 |
ASYMPTOMATIC BACTERIURIA |
1 |
0.0074 |
| 43 |
CRYPTOCOCCAL FUNGAEMIA |
1 |
0.0070 |
| 44 |
UMBILICAL CORD VASCULAR DISORDER |
1 |
0.0069 |
| 45 |
MENINGITIS VIRAL |
9 |
0.0066 |
| 46 |
COMPLICATIONS OF TRANSPLANTED LUNG |
2 |
0.0065 |
| 47 |
COOMBS DIRECT TEST POSITIVE |
2 |
0.0064 |
| 48 |
COLITIS EROSIVE |
1 |
0.0063 |
| 49 |
CYTOMEGALOVIRUS ANTIBODY POSITIVE |
1 |
0.0063 |
| 50 |
COMBINED IMMUNODEFICIENCY |
1 |
0.0062 |
| 51 |
HYPERCREATINAEMIA |
2 |
0.0060 |
| 52 |
VIRAEMIA |
8 |
0.0058 |
| 53 |
CRYPTOCOCCAL CUTANEOUS INFECTION |
1 |
0.0055 |
| 54 |
ELECTIVE SURGERY |
1 |
0.0054 |
| 55 |
BLOOD ALKALINE PHOSPHATASE |
1 |
0.0054 |
| 56 |
GENERALISED OEDEMA |
64 |
0.0052 |
| 57 |
C3 GLOMERULOPATHY |
1 |
0.0048 |
| 58 |
CYTOMEGALOVIRUS COLITIS |
11 |
0.0048 |
| 59 |
DISSEMINATED CYTOMEGALOVIRAL INFECTION |
1 |
0.0046 |
| 60 |
PLACENTA ACCRETA |
1 |
0.0046 |
| 61 |
KIDNEY DUPLEX |
1 |
0.0042 |
| 62 |
INTUBATION |
1 |
0.0040 |
| 63 |
SEPSIS SYNDROME |
2 |
0.0040 |
| 64 |
CEREBRAL CALCIFICATION |
1 |
0.0037 |
| 65 |
AMERICAN TRYPANOSOMIASIS |
1 |
0.0037 |
| 66 |
HEPATITIS C ANTIBODY POSITIVE |
1 |
0.0037 |
| 67 |
HYPOALDOSTERONISM |
1 |
0.0036 |
| 68 |
PERIVENTRICULAR LEUKOMALACIA |
1 |
0.0035 |
| 69 |
HELLP SYNDROME |
2 |
0.0033 |
| 70 |
TRANSFUSION-RELATED ACUTE LUNG INJURY |
1 |
0.0032 |
| 71 |
PARAPROTEINAEMIA |
1 |
0.0032 |
| 72 |
VIRAL LOAD INCREASED |
12 |
0.0031 |
| 73 |
LUNG TRANSPLANT REJECTION |
2 |
0.0030 |
| 74 |
PULMONARY VENO-OCCLUSIVE DISEASE |
2 |
0.0029 |
| 75 |
ACQUIRED DIAPHRAGMATIC EVENTRATION |
1 |
0.0028 |
| 76 |
TOXOPLASMOSIS |
3 |
0.0028 |
| 77 |
CYTOMEGALOVIRUS INFECTION |
45 |
0.0027 |
| 78 |
CENTRAL NERVOUS SYSTEM LEUKAEMIA |
1 |
0.0025 |
| 79 |
EPSTEIN-BARR VIRUS ANTIBODY POSITIVE |
1 |
0.0025 |
| 80 |
TOXIC NEUROPATHY |
1 |
0.0025 |
| 81 |
RESPIRATORY DISTRESS |
68 |
0.0025 |
| 82 |
BASAL GANGLIA HAEMORRHAGE |
2 |
0.0025 |
| 83 |
BREECH PRESENTATION |
3 |
0.0024 |
| 84 |
MYELOSUPPRESSION |
85 |
0.0024 |
| 85 |
ENTEROVIRUS INFECTION |
2 |
0.0023 |
| 86 |
AUTOIMMUNE THROMBOCYTOPENIA |
1 |
0.0023 |
| 87 |
IMMUNISATION |
1 |
0.0023 |
| 88 |
ASPERGILLOSIS |
3 |
0.0023 |
| 89 |
ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL |
1 |
0.0022 |
| 90 |
DRUG RESISTANCE |
57 |
0.0022 |
| 91 |
PULMONARY VASCULAR DISORDER |
1 |
0.0021 |
| 92 |
FOETAL DEATH |
11 |
0.0021 |
| 93 |
HAEMANGIOMA CONGENITAL |
1 |
0.0021 |
| 94 |
TRACHEAL STENOSIS |
1 |
0.0020 |
| 95 |
PREMATURE DELIVERY |
30 |
0.0019 |
| 96 |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS |
3 |
0.0019 |
| 97 |
BRONCHOSTENOSIS |
1 |
0.0018 |
| 98 |
LIFE SUPPORT |
1 |
0.0018 |
| 99 |
URINARY TRACT INFECTION FUNGAL |
1 |
0.0017 |
| 100 |
GRUNTING |
1 |
0.0017 |
| 101 |
HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL |
1 |
0.0016 |
| 102 |
BLOOD PRESSURE MEASUREMENT |
1 |
0.0016 |
| 103 |
GESTATIONAL HYPERTENSION |
2 |
0.0015 |
| 104 |
GUILLAIN-BARRE SYNDROME |
7 |
0.0014 |
| 105 |
FOETAL HEART RATE DECELERATION ABNORMALITY |
1 |
0.0014 |
| 106 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
3 |
0.0014 |
| 107 |
VIRAL HAEMORRHAGIC CYSTITIS |
1 |
0.0014 |
| 108 |
PANCYTOPENIA |
78 |
0.0014 |
| 109 |
ADENOVIRUS INFECTION |
4 |
0.0014 |
| 110 |
PHIMOSIS |
1 |
0.0014 |
| 111 |
DISSEMINATED CRYPTOCOCCOSIS |
1 |
0.0013 |
| 112 |
MONOCLONAL IMMUNOGLOBULIN PRESENT |
1 |
0.0013 |
| 113 |
FUNGAL PERITONITIS |
2 |
0.0013 |
| 114 |
CHRONIC ALLOGRAFT NEPHROPATHY |
1 |
0.0013 |
| 115 |
PLACENTA PRAEVIA |
1 |
0.0013 |
| 116 |
LUNG DISORDER |
61 |
0.0012 |
| 117 |
BOTULISM |
1 |
0.0012 |
| 118 |
TRANSFUSION REACTION |
1 |
0.0011 |
| 119 |
DRUG LEVEL FLUCTUATING |
1 |
0.0011 |
| 120 |
CYTOMEGALOVIRUS TEST POSITIVE |
2 |
0.0011 |
| 121 |
SERUM SICKNESS |
3 |
0.0011 |
| 122 |
NEONATAL RESPIRATORY DISTRESS |
1 |
0.0011 |
| 123 |
PNEUMONIA CRYPTOCOCCAL |
1 |
0.0011 |
| 124 |
MECHANICAL VENTILATION |
2 |
0.0011 |
| 125 |
CONTINUOUS HAEMODIAFILTRATION |
1 |
0.0010 |
| 126 |
TRANSPLANT REJECTION |
8 |
0.0010 |
| 127 |
PREMATURE BABY |
30 |
0.0010 |
| 128 |
LYMPHOPENIA |
14 |
0.0010 |
| 129 |
PATHOGEN RESISTANCE |
9 |
0.0010 |
| 130 |
POLYHYDRAMNIOS |
1 |
0.0010 |
| 131 |
GENOTYPE DRUG RESISTANCE TEST POSITIVE |
1 |
0.0010 |
| 132 |
MULTIPLE-DRUG RESISTANCE |
3 |
0.0010 |
| 133 |
HEART TRANSPLANT REJECTION |
1 |
0.0010 |
| 134 |
BLAST CELL COUNT INCREASED |
1 |
0.0010 |
| 135 |
PNEUMONIA VIRAL |
3 |
0.0009 |
| 136 |
PNEUMONIA STREPTOCOCCAL |
1 |
0.0009 |
| 137 |
RETINAL DETACHMENT |
8 |
0.0009 |
| 138 |
CEREBRAL VENTRICLE DILATATION |
1 |
0.0009 |
| 139 |
DERMATITIS EXFOLIATIVE GENERALISED |
3 |
0.0009 |
| 140 |
BONE MARROW TOXICITY |
1 |
0.0008 |
| 141 |
HAEMATOTOXICITY |
8 |
0.0008 |
| 142 |
VENOOCCLUSIVE DISEASE |
2 |
0.0008 |
| 143 |
SYSTEMIC CANDIDA |
2 |
0.0008 |
| 144 |
WHITE MATTER LESION |
1 |
0.0008 |
| 145 |
BRONCHIAL SECRETION RETENTION |
1 |
0.0008 |
| 146 |
MATERNAL DRUGS AFFECTING FOETUS |
6 |
0.0008 |
| 147 |
OBLITERATIVE BRONCHIOLITIS |
1 |
0.0008 |
| 148 |
LYMPHOCYTE PERCENTAGE DECREASED |
1 |
0.0007 |
| 149 |
BRONCHIAL OBSTRUCTION |
1 |
0.0007 |
| 150 |
PREMATURE LABOUR |
4 |
0.0007 |
| 151 |
DIABETES MELLITUS NON-INSULIN-DEPENDENT |
1 |
0.0007 |
| 152 |
CAESAREAN SECTION |
8 |
0.0007 |
| 153 |
GASTROINTESTINAL WALL THICKENING |
1 |
0.0007 |
| 154 |
FOETAL GROWTH RESTRICTION |
4 |
0.0007 |
| 155 |
PARAINFLUENZAE VIRUS INFECTION |
1 |
0.0007 |
| 156 |
IDIOPATHIC THROMBOCYTOPENIC PURPURA |
1 |
0.0006 |
| 157 |
PRE-ECLAMPSIA |
3 |
0.0006 |
| 158 |
PNEUMONIA LEGIONELLA |
1 |
0.0006 |
| 159 |
CRYPTOCOCCOSIS |
1 |
0.0006 |
| 160 |
ASPERGILLUS INFECTION |
4 |
0.0006 |
| 161 |
VENOOCCLUSIVE LIVER DISEASE |
3 |
0.0006 |
| 162 |
OLIGOHYDRAMNIOS |
2 |
0.0006 |
| 163 |
KIDNEY FIBROSIS |
1 |
0.0006 |
| 164 |
PULMONARY TOXICITY |
4 |
0.0006 |
| 165 |
EXPOSURE DURING PREGNANCY |
35 |
0.0006 |
| 166 |
LIVER TRANSPLANT REJECTION |
1 |
0.0006 |
| 167 |
PNEUMOMEDIASTINUM |
1 |
0.0006 |
| 168 |
PULMONARY ALVEOLAR HAEMORRHAGE |
3 |
0.0005 |
| 169 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
4 |
0.0005 |
| 170 |
JAUNDICE NEONATAL |
1 |
0.0005 |
| 171 |
LYMPHADENOPATHY MEDIASTINAL |
1 |
0.0005 |
| 172 |
HAEMOLYSIS |
4 |
0.0005 |
| 173 |
TRAUMATIC LUNG INJURY |
1 |
0.0005 |
| 174 |
BRONCHOPULMONARY ASPERGILLOSIS |
4 |
0.0005 |
| 175 |
RHINOVIRUS INFECTION |
2 |
0.0005 |
| 176 |
OCCULT BLOOD POSITIVE |
1 |
0.0005 |
| 177 |
PNEUMONIA STAPHYLOCOCCAL |
1 |
0.0005 |
| 178 |
ACUTE KIDNEY INJURY |
76 |
0.0005 |
| 179 |
HYPOSPADIAS |
1 |
0.0005 |
| 180 |
GASTROENTERITIS |
7 |
0.0005 |
| 181 |
CATHETER SITE ERYTHEMA |
1 |
0.0005 |
| 182 |
GRAFT VERSUS HOST DISEASE IN SKIN |
1 |
0.0005 |
| 183 |
PARESIS |
1 |
0.0004 |
| 184 |
CHOLESTATIC LIVER INJURY |
1 |
0.0004 |
| 185 |
MENINGITIS ASEPTIC |
2 |
0.0004 |
| 186 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
1 |
0.0004 |
| 187 |
NEPHROPATHY |
4 |
0.0004 |
| 188 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
12 |
0.0004 |
| 189 |
GRAFT VERSUS HOST DISEASE |
3 |
0.0004 |
| 190 |
KIDNEY TRANSPLANT REJECTION |
2 |
0.0004 |
| 191 |
PREMATURE RUPTURE OF MEMBRANES |
1 |
0.0004 |
| 192 |
CYTOPENIA |
5 |
0.0004 |
| 193 |
STEM CELL TRANSPLANT |
1 |
0.0004 |
| 194 |
URINARY TRACT INFECTION BACTERIAL |
1 |
0.0004 |
| 195 |
ANGLE CLOSURE GLAUCOMA |
1 |
0.0004 |
| 196 |
HAEMORRHAGIC STROKE |
3 |
0.0004 |
| 197 |
EXFOLIATIVE RASH |
1 |
0.0004 |
| 198 |
LUNG OPACITY |
1 |
0.0004 |
| 199 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
1 |
0.0004 |
| 200 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
1 |
0.0004 |
| 201 |
LUNG CONSOLIDATION |
1 |
0.0004 |
| 202 |
ENDOTRACHEAL INTUBATION |
1 |
0.0004 |
| 203 |
BACTERAEMIA |
4 |
0.0003 |
| 204 |
BRAIN HERNIATION |
1 |
0.0003 |
| 205 |
URINE ANALYSIS ABNORMAL |
1 |
0.0003 |
| 206 |
ATYPICAL PNEUMONIA |
1 |
0.0003 |
| 207 |
BRAIN DEATH |
1 |
0.0003 |
| 208 |
EPSTEIN-BARR VIRUS INFECTION |
2 |
0.0003 |
| 209 |
IRIDOCYCLITIS |
1 |
0.0003 |
| 210 |
FAECAL CALPROTECTIN INCREASED |
1 |
0.0003 |
| 211 |
STUPOR |
1 |
0.0003 |
| 212 |
BACTERIAL SEPSIS |
1 |
0.0003 |
| 213 |
HEPATIC NEOPLASM |
1 |
0.0003 |
| 214 |
HEPATOMEGALY |
3 |
0.0003 |
| 215 |
NEAR DEATH EXPERIENCE |
1 |
0.0003 |
| 216 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
1 |
0.0003 |
| 217 |
WOUND DEHISCENCE |
1 |
0.0003 |
| 218 |
BONE MARROW FAILURE |
6 |
0.0003 |
| 219 |
FOETAL EXPOSURE DURING PREGNANCY |
24 |
0.0003 |
| 220 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
2 |
0.0003 |
| 221 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
16 |
0.0003 |
| 222 |
HYPERREFLEXIA |
1 |
0.0003 |
| 223 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
5 |
0.0003 |
| 224 |
NEONATAL RESPIRATORY DISTRESS SYNDROME |
1 |
0.0003 |
| 225 |
LUNG TRANSPLANT |
1 |
0.0003 |
| 226 |
LEUKOPENIA |
14 |
0.0003 |
| 227 |
AMYLASE INCREASED |
1 |
0.0003 |
| 228 |
PULMONARY HAEMORRHAGE |
2 |
0.0003 |
| 229 |
PNEUMONIA FUNGAL |
1 |
0.0003 |
| 230 |
CANDIDIASIS |
1 |
0.0002 |
| 231 |
EXTRAVASATION |
1 |
0.0002 |
| 232 |
LUNG INFILTRATION |
2 |
0.0002 |
| 233 |
ILEUS PARALYTIC |
1 |
0.0002 |
| 234 |
HAEMOLYTIC ANAEMIA |
2 |
0.0002 |
| 235 |
IRON DEFICIENCY |
1 |
0.0002 |
| 236 |
SUSPECTED OFF LABEL USE |
1 |
0.0002 |
| 237 |
BREATH SOUNDS ABNORMAL |
1 |
0.0002 |
| 238 |
HYPERVOLAEMIA |
1 |
0.0002 |
| 239 |
DERMATITIS EXFOLIATIVE |
1 |
0.0002 |
| 240 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
2 |
0.0002 |
| 241 |
KLEBSIELLA INFECTION |
1 |
0.0002 |
| 242 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
2 |
0.0002 |
| 243 |
MALABSORPTION |
1 |
0.0002 |
| 244 |
RENAL IMPAIRMENT |
16 |
0.0002 |
| 245 |
CLOSTRIDIUM DIFFICILE COLITIS |
2 |
0.0002 |
| 246 |
DEAFNESS UNILATERAL |
1 |
0.0002 |
| 247 |
TREATMENT FAILURE |
15 |
0.0002 |
| 248 |
ELECTROLYTE IMBALANCE |
2 |
0.0002 |
| 249 |
PERIPHERAL SENSORY NEUROPATHY |
1 |
0.0002 |
| 250 |
HYPOVOLAEMIA |
1 |
0.0002 |
| 251 |
OFF LABEL USE |
146 |
0.0002 |
| 252 |
RESPIRATORY FAILURE |
12 |
0.0002 |
| 253 |
INFUSION SITE EXTRAVASATION |
1 |
0.0002 |
| 254 |
INFUSION SITE SWELLING |
1 |
0.0002 |
| 255 |
PROTEINURIA |
3 |
0.0002 |
| 256 |
PERITONITIS |
3 |
0.0001 |
| 257 |
ENCEPHALITIS |
1 |
0.0001 |
| 258 |
MENTAL STATUS CHANGES |
4 |
0.0001 |
| 259 |
LARGE INTESTINE PERFORATION |
1 |
0.0001 |
| 260 |
RIGHT VENTRICULAR FAILURE |
1 |
0.0001 |
| 261 |
RETINAL HAEMORRHAGE |
1 |
0.0001 |
| 262 |
PRODUCT SUPPLY ISSUE |
1 |
0.0001 |
| 263 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
1 |
0.0001 |
| 264 |
PSYCHIATRIC SYMPTOM |
1 |
0.0001 |
| 265 |
HEPATOTOXICITY |
3 |
0.0001 |
| 266 |
HAEMORRHAGE INTRACRANIAL |
2 |
0.0001 |
| 267 |
PLEURAL EFFUSION |
8 |
0.0001 |
| 268 |
LIPASE INCREASED |
1 |
0.0001 |
| 269 |
SHOCK |
3 |
0.0001 |
| 270 |
GASTROINTESTINAL INFLAMMATION |
1 |
0.0001 |
| 271 |
THROMBOCYTOPENIA |
14 |
0.0001 |
| 272 |
BLOOD DISORDER |
1 |
0.0001 |
| 273 |
SHOCK HAEMORRHAGIC |
1 |
0.0001 |
| 274 |
ESCHERICHIA INFECTION |
1 |
0.0001 |
| 275 |
DRUG LEVEL INCREASED |
2 |
0.0001 |
| 276 |
PERICARDITIS |
2 |
0.0001 |
| 277 |
HEPATITIS |
3 |
0.0001 |
| 278 |
PRODUCT USE ISSUE |
22 |
0.0001 |
| 279 |
NEUROTOXICITY |
2 |
0.0001 |
| 280 |
THERAPY NON-RESPONDER |
5 |
0.0001 |
| 281 |
DEVELOPMENTAL DELAY |
1 |
0.0001 |
| 282 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 283 |
ANAPHYLACTIC REACTION |
6 |
0.0001 |
| 284 |
BLOOD CREATININE INCREASED |
7 |
0.0001 |
| 285 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
1 |
0.0001 |
| 286 |
THROMBOTIC MICROANGIOPATHY |
1 |
0.0001 |
| 287 |
RESPIRATORY DISORDER |
3 |
0.0001 |
| 288 |
DRUG INEFFECTIVE |
132 |
0.0001 |
| 289 |
EMPHYSEMA |
1 |
0.0001 |
| 290 |
LIVER FUNCTION TEST INCREASED |
2 |
0.0001 |
| 291 |
SEPTIC SHOCK |
4 |
0.0001 |
| 292 |
PULMONARY THROMBOSIS |
1 |
0.0001 |
| 293 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0001 |
| 294 |
PERICARDIAL EFFUSION |
2 |
0.0001 |
| 295 |
NEOPLASM PROGRESSION |
3 |
0.0001 |
| 296 |
SPLENOMEGALY |
1 |
0.0001 |
| 297 |
HYPOXIA |
3 |
0.0001 |
| 298 |
MYOCLONUS |
1 |
0.0001 |
| 299 |
ADRENAL INSUFFICIENCY |
1 |
0.0001 |
| 300 |
CARDIOMEGALY |
1 |
0.0001 |
| 301 |
NEUTROPENIA |
11 |
0.0001 |
| 302 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 303 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 304 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 305 |
PNEUMONITIS |
2 |
0.0001 |
| 306 |
PRODUCT USE IN UNAPPROVED INDICATION |
18 |
0.0001 |
| 307 |
VISUAL IMPAIRMENT |
9 |
0.0001 |
| 308 |
FLUID OVERLOAD |
1 |
0.0001 |
| 309 |
ANAEMIA |
13 |
0.0001 |
| 310 |
ASCITES |
2 |
0.0001 |
| 311 |
TOXIC EPIDERMAL NECROLYSIS |
1 |
0.0001 |
| 312 |
LUNG INFECTION |
1 |
0.0001 |
| 313 |
THERAPY PARTIAL RESPONDER |
1 |
0.0001 |
| 314 |
NERVOUS SYSTEM DISORDER |
2 |
0.0001 |
| 315 |
SEPSIS |
7 |
0.0001 |
| 316 |
DRUG INTOLERANCE |
6 |
0.0001 |
| 317 |
VENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 318 |
RENAL FAILURE |
8 |
0.0001 |
| 319 |
GASTROINTESTINAL HAEMORRHAGE |
5 |
0.0001 |
| 320 |
HEMIPARESIS |
1 |
0.0001 |
| 321 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 322 |
HAEMATURIA |
2 |
0.0001 |
| 323 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 324 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
| 325 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 326 |
INTENTIONAL PRODUCT USE ISSUE |
5 |
0.0001 |
| 327 |
HYPERKALAEMIA |
2 |
0.0001 |
| 328 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 329 |
HEPATIC FUNCTION ABNORMAL |
2 |
0.0001 |
| 330 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 331 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 332 |
PYREXIA |
18 |
0.0001 |
| 333 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 334 |
EAR PAIN |
1 |
0.0001 |
| 335 |
CHILLS |
6 |
0.0001 |
| 336 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
2 |
0.0001 |
| 337 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 338 |
PREGNANCY |
1 |
0.0000 |
| 339 |
ABORTION SPONTANEOUS |
2 |
0.0000 |
| 340 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 341 |
HAEMOGLOBIN DECREASED |
5 |
0.0000 |
| 342 |
PULMONARY HYPERTENSION |
1 |
0.0000 |
| 343 |
CARDIO-RESPIRATORY ARREST |
2 |
0.0000 |
| 344 |
MOUTH ULCERATION |
1 |
0.0000 |
| 345 |
DEEP VEIN THROMBOSIS |
3 |
0.0000 |
| 346 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 347 |
INFUSION RELATED REACTION |
3 |
0.0000 |
| 348 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 349 |
SKIN DISCOLOURATION |
2 |
0.0000 |
| 350 |
HYPOKALAEMIA |
2 |
0.0000 |
| 351 |
PULMONARY EMBOLISM |
4 |
0.0000 |
| 352 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 353 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 354 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 355 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 356 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 357 |
FLUID RETENTION |
2 |
0.0000 |
| 358 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 359 |
RASH GENERALISED |
1 |
0.0000 |
| 360 |
HAEMATOMA |
1 |
0.0000 |
| 361 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 362 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 363 |
PALLOR |
1 |
0.0000 |
| 364 |
TREATMENT NONCOMPLIANCE |
2 |
0.0000 |
| 365 |
HYPONATRAEMIA |
2 |
0.0000 |
| 366 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 367 |
DISEASE PROGRESSION |
4 |
0.0000 |
| 368 |
RENAL INJURY |
1 |
0.0000 |
| 369 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 370 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 371 |
FUNGAL INFECTION |
1 |
0.0000 |
| 372 |
FLUSHING |
3 |
0.0000 |
| 373 |
HEPATIC ENZYME INCREASED |
2 |
0.0000 |
| 374 |
GASTRIC DISORDER |
1 |
0.0000 |
| 375 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 376 |
DYSARTHRIA |
1 |
0.0000 |
| 377 |
COLITIS |
1 |
0.0000 |
| 378 |
CARDIAC ARREST |
2 |
0.0000 |
| 379 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 380 |
BALANCE DISORDER |
2 |
0.0000 |
| 381 |
VAGINAL HAEMORRHAGE |
1 |
0.0000 |
| 382 |
COLITIS ULCERATIVE |
1 |
0.0000 |
| 383 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 384 |
NO ADVERSE EVENT |
4 |
0.0000 |
| 385 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 386 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 387 |
BLOOD PRESSURE INCREASED |
3 |
0.0000 |
| 388 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 389 |
HAEMORRHAGE |
2 |
0.0000 |
| 390 |
DRUG INTERACTION |
3 |
0.0000 |
| 391 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 392 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
| 393 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 394 |
OEDEMA |
1 |
0.0000 |
| 395 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 396 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 397 |
CONVULSION |
1 |
0.0000 |
| 398 |
LETHARGY |
1 |
0.0000 |
| 399 |
SEIZURE |
2 |
0.0000 |
| 400 |
BONE PAIN |
1 |
0.0000 |
| 401 |
IRRITABILITY |
1 |
0.0000 |
| 402 |
OEDEMA PERIPHERAL |
2 |
0.0000 |
| 403 |
FEELING HOT |
1 |
0.0000 |
| 404 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 405 |
CHEST PAIN |
3 |
0.0000 |
| 406 |
PNEUMONIA |
5 |
0.0000 |
| 407 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 408 |
HYPOTENSION |
3 |
0.0000 |
| 409 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 410 |
SLEEP DISORDER |
1 |
0.0000 |
| 411 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 412 |
DIARRHOEA |
9 |
0.0000 |
| 413 |
VOMITING |
6 |
0.0000 |
| 414 |
HEADACHE |
8 |
0.0000 |
| 415 |
PARAESTHESIA |
2 |
0.0000 |
| 416 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 417 |
TOXICITY TO VARIOUS AGENTS |
2 |
0.0000 |
| 418 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 419 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 420 |
TACHYCARDIA |
1 |
0.0000 |
| 421 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 422 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 423 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 424 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 425 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 426 |
NAUSEA |
8 |
0.0000 |
| 427 |
CONDITION AGGRAVATED |
3 |
0.0000 |
| 428 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 429 |
DYSPNOEA |
5 |
0.0000 |
| 430 |
DEHYDRATION |
1 |
0.0000 |
| 431 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 432 |
WEIGHT DECREASED |
2 |
0.0000 |
| 433 |
ANXIETY |
2 |
0.0000 |
| 434 |
INFECTION |
1 |
0.0000 |
| 435 |
MALAISE |
3 |
0.0000 |
| 436 |
TREMOR |
1 |
0.0000 |
| 437 |
FALL |
2 |
0.0000 |
| 438 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 439 |
MUSCLE SPASMS |
1 |
0.0000 |
| 440 |
HYPERTENSION |
1 |
0.0000 |
| 441 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 442 |
COUGH |
1 |
0.0000 |
| 443 |
DEATH |
3 |
0.0000 |
| 444 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 445 |
ASTHENIA |
1 |
0.0000 |
| 446 |
PRURITUS |
1 |
0.0000 |
| 447 |
RASH |
1 |
0.0000 |
| 448 |
PAIN |
1 |
0.0000 |